Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Jonathan Sheena sold 335 shares of the stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $40.19, for a total value of $13,463.65. Following the completion of the sale, the insider now owns 484,743 shares of the company’s stock, […]
Natera (NASDAQ:NTRA – Free Report) had its price objective decreased by The Goldman Sachs Group from $60.00 to $52.00 in a research note released on Friday, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the medical research company’s stock. Several other equities analysts have also recently issued reports on NTRA. Sanford […]
EFG Asset Management North America Corp. boosted its holdings in Natera, Inc. (NASDAQ:NTRA – Free Report) by 1.9% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 130,051 shares of the medical research company’s stock after acquiring an additional 2,390 shares during the […]
Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report)’s stock price dropped 7.1% during mid-day trading on Thursday . The company traded as low as $41.56 and last traded at $41.64. Approximately 363,463 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 1,205,238 shares. The stock had previously closed at […]